IRIS
RUSSO, Simonetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 924
NA - Nord America 772
AS - Asia 389
AF - Africa 21
SA - Sud America 1
Totale 2.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 769
CN - Cina 286
FI - Finlandia 219
IT - Italia 219
IE - Irlanda 187
SE - Svezia 151
DE - Germania 78
TR - Turchia 58
FR - Francia 30
SG - Singapore 26
CI - Costa d'Avorio 21
UA - Ucraina 12
BE - Belgio 11
IN - India 10
GB - Regno Unito 7
CZ - Repubblica Ceca 5
CA - Canada 3
HU - Ungheria 3
TW - Taiwan 3
KR - Corea 2
RU - Federazione Russa 2
VN - Vietnam 2
BR - Brasile 1
JP - Giappone 1
PK - Pakistan 1
Totale 2.107
Salva come PNG Salva come JPEG
Città #
Chandler 191
Dublin 187
Ann Arbor 114
Parma 111
Beijing 63
Dearborn 51
Izmir 47
Shanghai 41
Nanjing 39
Ashburn 36
Jacksonville 30
Princeton 28
Bremen 27
Wilmington 24
Abidjan 21
New York 18
Helsinki 17
Singapore 17
Kunming 13
Shenyang 13
Hebei 11
Hefei 11
Nanchang 11
Boardman 10
Brussels 10
Düsseldorf 10
Los Angeles 10
San Mateo 10
Dallas 9
Grafing 8
Hangzhou 8
Jinan 8
Kocaeli 8
Guangzhou 7
Munich 7
Fremont 6
Jiaxing 6
Modena 6
Seattle 6
Changsha 5
Milan 5
Prata Di Pordenone 5
Woodbridge 5
Zhengzhou 5
Des Moines 4
Fuzhou 4
Hyderabad 4
Palermo 4
Sant'ilario D'enza 4
Ankara 3
Brno 3
Fairfield 3
Haikou 3
Norwalk 3
Pune 3
Tianjin 3
Toronto 3
Torrance 3
Vigevano 3
Brescia 2
Caorso 2
Carpi 2
Dong Ket 2
Highland Park 2
Houston 2
Lissone 2
Magdeburg 2
Montegaldella 2
Ningbo 2
Rimini 2
Soliera 2
Taipei 2
Taizhou 2
Trezzano Sul Naviglio 2
Ulsan 2
Xian 2
Amherst 1
Auburn Hills 1
Bologna 1
Borås 1
Chicago 1
Cremona 1
Frontone 1
Gatchina 1
Leipzig 1
Leuven 1
Messina 1
Mumbai 1
Nashville 1
New Delhi 1
Noceto 1
Orange 1
Parabita 1
Paris 1
Pavia 1
Poggio Renatico 1
Redmond 1
Reggio Nell'emilia 1
Rho 1
San Giuliano Milanese 1
Totale 1.383
Salva come PNG Salva come JPEG
Nome #
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 151
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 132
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 124
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 112
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 101
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 98
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 92
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 88
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 80
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 77
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 76
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 74
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 74
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 72
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 71
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 69
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 67
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 67
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey 67
Structure activity relationship of new EphA2 ligands 65
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 65
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 61
Mannich base derivatives as novel EGFR irreversible inhibitors 56
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 54
Target-hopping: a useful approach to identify novel Eph receptor antagonists 51
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism 51
Structure-activity realtionships of new EphaA2 ligands 43
Mechanical vibrations applied to nondestructive evaluation of materials and structures 33
Totale 2.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 60 13 11 19 48 47 10 41 37 8 9
2020/2021201 9 8 14 15 14 18 19 8 36 25 17 18
2021/2022179 9 10 9 38 4 11 14 11 5 12 8 48
2022/2023668 75 84 25 53 70 75 12 36 219 4 13 2
2023/2024219 16 16 5 9 8 35 32 21 10 10 21 36
2024/202548 27 21 0 0 0 0 0 0 0 0 0 0
Totale 2.171